These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 189543)

  • 1. A behavior of Y chromatin in cancer cells of males.
    Takahashi M
    Acta Cytol; 1977; 21(1):132-6. PubMed ID: 189543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative studies of Y chromosomal fluorescence in human interphase nuclei.
    Lamborot-Manzur M; Tishler PV; Atkins L
    Clin Genet; 1972; 3(2):103-15. PubMed ID: 4115478
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of numerical chromosomal abnormalities in malignant cells in fine needle aspirates by fluorescence in situ hybridization of interphase cell nuclei with chromosome-specific probes.
    Cajulis RS; Frias-Hidvegi D
    Acta Cytol; 1993; 37(3):391-6. PubMed ID: 8388611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the Y chromosome on the morphology of human F-chromatin under normal and pathological conditions].
    Kulikov RI
    Tsitologiia; 1977 Jul; 19(7):732-8. PubMed ID: 73242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interphase cytogenetics of gastric and esophageal adenocarcinomas.
    Rao PH; Mathew S; Lauwers G; Rodriguez E; Kelsen DP; Chaganti RS
    Diagn Mol Pathol; 1993 Dec; 2(4):264-8. PubMed ID: 8118604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 46,XY lung adenocarcinoma in a 46,XX female patient: a possible parental transmission.
    Genest P; Lagacé R; Bouillant A; Dumas L; Bonenfant JL
    Acta Cytol; 1979; 23(3):237-44. PubMed ID: 294062
    [No Abstract]   [Full Text] [Related]  

  • 7. Chromosome abnormalities as primary events in human malignant disease: evidence from marker chromosomes.
    Atkin NB; Baker MC
    J Natl Cancer Inst; 1966 Mar; 36(3):539-57. PubMed ID: 18630328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patients.
    Dave BJ; Risin SA; Spitz MR; Pathak S
    Anticancer Res; 1996; 16(3A):1187-92. PubMed ID: 8702234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Y chromosome abnormality in human stomach and lung cancer.
    Wada M; Yokota J; Mizoguchi H; Terada M; Sugimura T
    Jpn J Cancer Res; 1987 Aug; 78(8):780-3. PubMed ID: 3115923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between fluorescence in situ hybridization and classical cytogenetics in human tumors.
    Virmani AK; Tonk VS; Gazdar AF
    Anticancer Res; 1998; 18(3A):1351-6. PubMed ID: 9673339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The types and breakpoints of somatic chromosome aberrations in small cell lung cancer (SCLC) patients and heavy smokers].
    Su YA; Wang XQ; Wu M; Tang ZZ; Kong LH; Wang YL; Chen ZM
    Yi Chuan Xue Bao; 1988; 15(2):150-60. PubMed ID: 2856226
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytogenetic analysis of lung tumors by in situ hybridization with chromosome-specific DNA probes].
    Miyamoto H; Kato M; Ishikuro A; Akita H; Kawakami Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():33-8. PubMed ID: 1306236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytogenetic studies of lung cancer].
    Fang Y
    Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):249-52. PubMed ID: 3248479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different vulnerability among chromosomes to numerical instability in gastric carcinogenesis: stage-dependent analysis by FISH with the use of microwave irradiation.
    Kitayama Y; Igarashi H; Sugimura H
    Clin Cancer Res; 2000 Aug; 6(8):3139-46. PubMed ID: 10955795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the mitochondrial displacement loop in lung cancers.
    Suzuki M; Toyooka S; Miyajima K; Iizasa T; Fujisawa T; Bekele NB; Gazdar AF
    Clin Cancer Res; 2003 Nov; 9(15):5636-41. PubMed ID: 14654546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
    Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
    Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tumors and the absence of Y chromosomes and Y chromatin in solid tumors in males].
    Vass L; Sellyei M
    Orv Hetil; 1973 Nov; 114(46):2770-4. PubMed ID: 4754506
    [No Abstract]   [Full Text] [Related]  

  • 18. Chromosome abnormalities in 10 lung cancer cell lines of the NCI-H series analyzed with spectral karyotyping.
    Grigorova M; Lyman RC; Caldas C; Edwards PA
    Cancer Genet Cytogenet; 2005 Oct; 162(1):1-9. PubMed ID: 16157194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonrandom chromosomal numerical abnormality as a new molecular cytogenetic tumor marker--a retrospective study of 60 gastric cancer cases.
    Kitayama Y; Sugimura H
    Rinsho Byori; 2005 Oct; 53(10):881-6. PubMed ID: 16296333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant tumors of the same type in twins and siblings].
    Cserháti G; Szilágyi J
    Orv Hetil; 1979 May; 120(20):1195-6. PubMed ID: 450454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.